Version 1
: Received: 18 March 2024 / Approved: 18 March 2024 / Online: 19 March 2024 (02:25:56 CET)
How to cite:
Oishi, T.; Yasui, Y.; Kato, A.; Ogita, S.; Eitoku, T.; Enoki, H.; Nakano, T. Analysis of Cell Immunity for Children Infected with COVID-19 and Those Vaccinated against COVID-19 Using T-SPOT®.COVID. Preprints2024, 2024031033. https://doi.org/10.20944/preprints202403.1033.v1
Oishi, T.; Yasui, Y.; Kato, A.; Ogita, S.; Eitoku, T.; Enoki, H.; Nakano, T. Analysis of Cell Immunity for Children Infected with COVID-19 and Those Vaccinated against COVID-19 Using T-SPOT®.COVID. Preprints 2024, 2024031033. https://doi.org/10.20944/preprints202403.1033.v1
Oishi, T.; Yasui, Y.; Kato, A.; Ogita, S.; Eitoku, T.; Enoki, H.; Nakano, T. Analysis of Cell Immunity for Children Infected with COVID-19 and Those Vaccinated against COVID-19 Using T-SPOT®.COVID. Preprints2024, 2024031033. https://doi.org/10.20944/preprints202403.1033.v1
APA Style
Oishi, T., Yasui, Y., Kato, A., Ogita, S., Eitoku, T., Enoki, H., & Nakano, T. (2024). Analysis of Cell Immunity for Children Infected with COVID-19 and Those Vaccinated against COVID-19 Using T-SPOT®.COVID. Preprints. https://doi.org/10.20944/preprints202403.1033.v1
Chicago/Turabian Style
Oishi, T., Hideo Enoki and Takashi Nakano. 2024 "Analysis of Cell Immunity for Children Infected with COVID-19 and Those Vaccinated against COVID-19 Using T-SPOT®.COVID" Preprints. https://doi.org/10.20944/preprints202403.1033.v1
Abstract
To elucidate the cellular immune response to coronavirus disease (COVID-19) among children, we assessed cellular immunity in 8 children post-vaccination for COVID-19 and 11 children after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, using the T-SPOT®.COVID assay for both the spike (S) and nucleocapsid (N) proteins. In the vaccinated group, the T-SPOT®.COVID assay for the S protein yielded positive results in all eight children. In contrast, in the post-infection group, the assay for the N protein was positive in 5 of 11 children, with 3 of these 5 children requiring hospital admission, including 2 who needed mechanical ventilation. Therefore, the T-SPOT®.COVID assay is valuable for assessing cellular immunity against COVID-19, and most children infected with COVID-19 may not develop such immunity unless the disease severity is significant.
Keywords
cell immunity; COVID-19; children; T-Spot®
Subject
Medicine and Pharmacology, Pediatrics, Perinatology and Child Health
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.